Genus plc (LON:GNS – Get Rating) has received a consensus rating of “Hold” from the seven brokerages that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is GBX 5,391.43 ($68.21).
Separately, Peel Hunt reiterated a “hold” rating and issued a GBX 4,500 ($56.93) target price on shares of Genus in a research note on Tuesday, April 12th.
Shares of GNS stock opened at GBX 2,704 ($34.21) on Wednesday. The company has a current ratio of 1.77, a quick ratio of 1.13 and a debt-to-equity ratio of 37.36. The stock has a market capitalization of £1.78 billion and a price-to-earnings ratio of 48.22. Genus has a twelve month low of GBX 2,186 ($27.66) and a twelve month high of GBX 6,310 ($79.83). The stock has a fifty day simple moving average of GBX 2,643.65 and a two-hundred day simple moving average of GBX 3,613.56.
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
- There Are Cracks In The Paint At Sherwin-Williams
- American Well Corporation Stock May Well Be Bottoming
- 3 Outperforming Energy Stocks with More in the Tank
- Three Beaten Down Stocks The Insiders Are Buying
- Should Medtronic Make the Cut For Your Recovery Watchlist?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.